The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 69 | 12.8x | 20.1x | Above average | |
Growth | 57 | 20.7% | 5.6% | Near average | |
Quality | 81 | 41.9% | 7.6% | Above average | |
Safety | 83 | -2.8x | 0.4x | Above average | |
Capital Return | 79 | — | 2.19% | Above average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Harmony Biosciences Holdings, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Harmony Biosciences Holdings, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
HRMY stock witnessed a decrease in the average target price by 8.12% to reach $43 compared to $46.8 last month, despite the number of analysts remaining steady at 5. The variance between the low estimate ($31) and the high estimate ($50) indicates a gap in expectations; however, the current price ($30.15) is still trading below the lowest analyst estimate, reflecting market caution that exceeds the analysts' own reservations.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.